Global Custom Market Research Reports Provider Company

phone

Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update

  • Published Date: 27 Dec 2018
  • Number of Pages: 32
  • Category: Company Profile
  • Country: United States of America
Summary

Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, point of care, DZ lite instrument, analyzer parameters, data sheets. Diazyme Laboratories offers anemia markers, cancer markers, cardiovascular markers, coagulation markers, diabetic markers, electrolyte markers, inflammatory markers, liver markers, renal and pancreatic marker, sepsis marker and vitamin marker. The companys technology comprise enzyme cycling technology, latex enhanced immunoassay and enzyme-immunoassay. Diazyme Laboratories is headquartered in Poway, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diazyme Laboratories Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy
:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Diazyme Laboratories Inc Company Overview 5
Diazyme Laboratories Inc Company Snapshot 5
Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Diazyme Laboratories Inc Pipeline Analysis Overview 8
Diazyme Laboratories Inc - Key Facts 8
Diazyme Laboratories Inc - Major Products and Services 9
Diazyme Laboratories Inc Pipeline Products by Development Stage 10
Diazyme Laboratories Inc Pipeline Products Overview 12
B7-H4 Assay 12
B7-H4 Assay Product Overview 12
DcR3 (DD-C248) Assay 13
DcR3 (DD-C248) Assay Product Overview 13
MIC-1 (DD-X065) Assay 14
MIC-1 (DD-X065) Assay Product Overview 14
ProADM Point-of-Care 15
ProADM Point-of-Care Product Overview 15
ProADM Test 16
ProADM Test Product Overview 16
ProANP Test 17
ProANP Test Product Overview 17
ProET1 Test 18
ProET1 Test Product Overview 18
Spondin-2 (DD-P108) Assay 19
Spondin-2 (DD-P108) Assay Product Overview 19
TRAIL-R2 Assay 20
TRAIL-R2 Assay Product Overview 20
Diazyme Laboratories Inc - Key Competitors 21
Diazyme Laboratories Inc - Key Employees 22
Diazyme Laboratories Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Diazyme Laboratories Inc, Recent Developments 24
Jul 16, 2018: Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories 24
Jan 25, 2018: Strykers DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association 24
Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers 25
Jun 21, 2017: Beckman Coulter Diagnostics Expands Chemistry Menu to Include FDA-cleared Procalcitonin 25
Nov 28, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Direct HbA1c (Enzymatic, On-Board Lysis) Assay for Clinical Chemistry Analyzers 25
Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Folate Assay for Clinical Chemistry Analyzers 26
Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin B12 Assay for Clinical Chemistry Analyzers 26
Jul 22, 2016: Get Reliable Results with the Diazyme 25-OH Vitamin D Assay for Clinical Chemistry Analyzers 26
May 23, 2016: Diadexus and Sonic Healthcare USA Sign National Agreement for PLAC Activity Test 27
Nov 10, 2015: Diadexus Presents New PLAC Activity Data From the REGARDS Study at 2015 American Heart Association Scientific Sessions 27
Appendix 29
Methodology 29
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables


Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Diazyme Laboratories Inc Pipeline Products by Equipment Type 6
Diazyme Laboratories Inc Pipeline Products by Indication 7
Diazyme Laboratories Inc, Key Facts 8
Diazyme Laboratories Inc, Major Products and Services 9
Diazyme Laboratories Inc Number of Pipeline Products by Development Stage 10
Diazyme Laboratories Inc Pipeline Products Summary by Development Stage 11
B7-H4 Assay - Product Status 12
B7-H4 Assay - Product Description 12
DcR3 (DD-C248) Assay - Product Status 13
DcR3 (DD-C248) Assay - Product Description 13
MIC-1 (DD-X065) Assay - Product Status 14
MIC-1 (DD-X065) Assay - Product Description 14
ProADM Point-of-Care - Product Status 15
ProADM Point-of-Care - Product Description 15
ProADM Test - Product Status 16
ProADM Test - Product Description 16
ProANP Test - Product Status 17
ProANP Test - Product Description 17
ProET1 Test - Product Status 18
ProET1 Test - Product Description 18
Spondin-2 (DD-P108) Assay - Product Status 19
Spondin-2 (DD-P108) Assay - Product Description 19
TRAIL-R2 Assay - Product Status 20
TRAIL-R2 Assay - Product Description 20
Diazyme Laboratories Inc, Key Employees 22
Diazyme Laboratories Inc, Subsidiaries 23
Glossary 31

List Of Figures


Diazyme Laboratories Inc Pipeline Products by Equipment Type 6
Diazyme Laboratories Inc Pipeline Products by Development Stage 10

SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to

View Report

Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products

View Report

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports